Oral Mucositis Market is expected to reach US$ 2.21 Billion by 2033 | Major key players - Amgen Inc., Valerio Therapeutics, Enlivity Corporation.

Market Size and Forecast:

The Global Oral Mucositis Market size reached US$ 1.15 Billion in 2024 from US$ 1.07 Billion in 2023 and is expected to reach US$ 2.21 Billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033. The Market is driven by the rising prevalence of cancer patients undergoing chemotherapy and radiotherapy, coupled with increasing adoption of advanced therapeutic solutions. According to DataM Intelligence

To Download a Free Sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/oral-mucositis-market?sz

The Oral Mucositis Market refers to the global industry focused on diagnosing, preventing, and treating inflammation and ulceration of the mucous membranes in the mouth, commonly caused by chemotherapy and radiotherapy. It includes pharmaceutical therapies, mouth rinses, pain management solutions, and emerging biologics aimed at improving patient comfort and treatment outcomes in oncology care.

Industry Recent Developments: United States

✅ October 2025: Increased focus on novel oral mucositis therapies from prominent companies like OncoZenge, EpicentRx, and Prothex Pharma developing innovative drugs expected to enter the market soon, changing its dynamics. This is driven by higher cancer incidence and research investments.

✅ September 2025: The oral mucositis treatment market size in the U.S. was valued at USD 0.54 billion in 2024 and expected to reach USD 0.93 billion by 2032, growing at a CAGR of 7.03%, supported by high cancer burden and well-established healthcare infrastructure.

✅ August 2025: Ongoing growth driven by rising cancer cases, chemotherapy, radiation treatments, and increased awareness and improved supportive care practices, with a market size of around USD 1.61 billion forecasted in 2025 for the overall oral mucositis market in North America.

Industry Recent Developments: Japan

✅ October 2025: The oral mucositis treatment drug market in Japan was valued around USD 0.2 billion in recent years and projected to grow steadily, driven by the increasing demand for therapies targeting chemotherapy-induced oral mucositis.

✅ September 2025: Growing adoption of advanced supportive cancer care treatments and targeted therapies in Japan, contributing to the expansion of the chemotherapy-induced oral mucositis market, valued within a global context of increasing incidences and awareness.

✅ August 2025: Increased focus on developing personalized medicine and innovative drug delivery systems for oral mucositis in Japan, along with advancement in tissue engineering and regenerative therapies, supporting market growth through 2025 and beyond.

Get Customization in the report as per your requirements + Exclusive Bundle & Multi-User Discounts: https://datamintelligence.com/customize/oral-mucositis-market?sz

Notable Regulatory Actions (2025):

✅ Avasopasem (Galera/Galera data / regulatory status): Phase-3 ROMAN results and follow-up analyses were published in 2025 showing benefit signals for reduction of SOM, but regulators (FDA) had previously requested confirmatory data / issued a Complete Response Letter (CRL) in earlier reviews - meaning the program remained under additional review requirements rather than receiving approval in 2025.

✅ Dusquetide / Soligenix (SGX942 / SGX945): Soligenix continued clinical development and corporate updates in 2025 (Phase 2/3 history and program milestones), but no FDA approval for oral-mucositis indication was recorded in 2025. The company positioned dusquetide programally and reported upcoming data/milestones in 2025.

✅ Label / related drug labels mentioning stomatitis/mucositis: Some oncology drug labels and product materials referenced management of stomatitis/mucositis events (e.g., label excerpts for other oncology agents mention stomatitis rates), but these are safety/labeling notes for those drugs - not new approvals for mucositis therapies.

Major Key Players:

Amgen Inc.
Valerio Therapeutics
Napo Pharmaceuticals, Inc.
Enlivity Corporation
MuReva Phototherapy Inc.
Innovation Pharmaceuticals
Monopar Therapeutics Inc.
EpicentRx, Inc.

Segments Covered in the Oral Mucositis Market:

By Drug Class: Antibiotics, Anti-Fungal Drugs, Anti-Viral Drugs, Anti-Inflammatory Drugs, Anti-Neoplastic Drugs, Others.

By Cause: Chemotherapy-Induced Oral Mucositis, Radiotherapy-Induced Oral Mucositis, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis for Oral Mucositis Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=oral-mucositis-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Oral Mucositis market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Oral Mucositis Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Oral Mucositis market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Oral Mucositis Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Oral Mucositis market?

➠ Who are the global key manufacturers of the Oral Mucositis Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Oral Mucositis market opportunities and threats faced by the vendors in the global Oral Mucositis Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Oral Mucositis market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.